Home › Therapeutic areas › Infectious Disease › RSV

RSV (2 companies)

Companies with an active program in RSV.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 2 Approved $253M 8
IVVD Invivyd Infectious Disease 1 Approved $152M 5